What does remeasurement of embedded lease liabilities mean?

Represents adjustments to the carrying value of lease liabilities resulting from changes in lease terms, index-based payments, or reassessments of lease duration. This non-cash activity reflects the ongoing management of long-term operating obligations. It helps investors track the volatility and sensitivity of lease-related debt to external economic factors.

Sarepta Therapeutics, Inc. SRPT Remeasurement Of Embedded Lease Liabilities

Remeasurement Of Embedded Lease Liabilities at other companies

Viridian Therapeutics, Inc.VRDN

$0-100%

Andersen Group ANDG

-$437.75K—

KEE

Keel Infrastructure Corp. Common StockKEEL

$2.5M+583%

Lyft, Inc.LYFT

-$8.23M-6.2%

KEE

Keel Infrastructure Corp. Common StockKEEL

$2.5M+583%

Flutter EntertainmentFLUT

$13M-48.0%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept srpt:RemeasurementOfEmbeddedLeaseLiabilities.

The official record: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s remeasurement of embedded lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s remeasurement of embedded lease liabilities?: Sarepta Therapeutics, Inc. (SRPT) reported remeasurement of embedded lease liabilities of $3.07M in Q4 2025.
What does remeasurement of embedded lease liabilities mean?: Represents adjustments to the carrying value of lease liabilities resulting from changes in lease terms, index-based payments, or reassessments of lease duration. This non-cash activity reflects the ongoing management of long-term operating obligations. It helps investors track the volatility and sensitivity of lease-related debt to external economic factors.